Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Der Internist
|
February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]
J Havla, T Kümpfel, R Hohlfeld
HNO
|
February 3, 2009
[Reproducibility and reliability of phonovibrograms. Quantification of healthy vocal fold vibrations]
J Havla, M Döllinger, U Eysholdt, et al.
European Journal of Neurology
|
April 17, 2024
Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndrome
E Mulazzani, L Böhm, T Christmann, et al.
Multiple Sclerosis and Related Disorders
|
September 20, 2022
Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?
J A Gernert, H Zimmermann, E Oswald, et al.
Frontiers in Immunology
|
September 2, 2024
High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis
S Samadzadeh, J Havla, K Lepka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 17, 2012
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis
T Kümpfel, L-A Gerdes, T Wacker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
J Havla, A Berthele, T Kümpfel, et al.
Neurology
|
April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H L Pellkofer, M Krumbholz, A Berthele, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis
Marcus Unterrainer, C Mahler, L Vomacka, et al.
European Journal of Neurology
|
June 27, 2020
Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis
L Aly, J Havla, G Lepennetier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Der Internist
|
February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]
J Havla, T Kümpfel, R Hohlfeld
HNO
|
February 3, 2009
[Reproducibility and reliability of phonovibrograms. Quantification of healthy vocal fold vibrations]
J Havla, M Döllinger, U Eysholdt, et al.
European Journal of Neurology
|
April 17, 2024
Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndrome
E Mulazzani, L Böhm, T Christmann, et al.
Multiple Sclerosis and Related Disorders
|
September 20, 2022
Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?
J A Gernert, H Zimmermann, E Oswald, et al.
Frontiers in Immunology
|
September 2, 2024
High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis
S Samadzadeh, J Havla, K Lepka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 17, 2012
Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis
T Kümpfel, L-A Gerdes, T Wacker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 6, 2012
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
J Havla, A Berthele, T Kümpfel, et al.
Neurology
|
April 13, 2011
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H L Pellkofer, M Krumbholz, A Berthele, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis
Marcus Unterrainer, C Mahler, L Vomacka, et al.
European Journal of Neurology
|
June 27, 2020
Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis
L Aly, J Havla, G Lepennetier, et al.
Page
of 2